187 related articles for article (PubMed ID: 20160040)
1. Thioredoxin reductase-1 mediates curcumin-induced radiosensitization of squamous carcinoma cells.
Javvadi P; Hertan L; Kosoff R; Datta T; Kolev J; Mick R; Tuttle SW; Koumenis C
Cancer Res; 2010 Mar; 70(5):1941-50. PubMed ID: 20160040
[TBL] [Abstract][Full Text] [Related]
2. The chemopreventive agent curcumin is a potent radiosensitizer of human cervical tumor cells via increased reactive oxygen species production and overactivation of the mitogen-activated protein kinase pathway.
Javvadi P; Segan AT; Tuttle SW; Koumenis C
Mol Pharmacol; 2008 May; 73(5):1491-501. PubMed ID: 18252805
[TBL] [Abstract][Full Text] [Related]
3. The chemopreventive and clinically used agent curcumin sensitizes HPV (-) but not HPV (+) HNSCC to ionizing radiation, in vitro and in a mouse orthotopic model.
Tuttle S; Hertan L; Daurio N; Porter S; Kaushick C; Li D; Myamoto S; Lin A; O'Malley BW; Koumenis C
Cancer Biol Ther; 2012 May; 13(7):575-84. PubMed ID: 22441776
[TBL] [Abstract][Full Text] [Related]
4. Radiosensitization by 2-deoxy-D-glucose and 6-aminonicotinamide involves activation of redox sensitive ASK1-JNK/p38MAPK signaling in head and neck cancer cells.
Sharma PK; Dwarakanath BS; Varshney R
Free Radic Biol Med; 2012 Oct; 53(7):1500-13. PubMed ID: 22824861
[TBL] [Abstract][Full Text] [Related]
5. Curcumin potentiates laryngeal squamous carcinoma radiosensitivity via NF-ΚB inhibition by suppressing IKKγ expression.
Deng XZ; Geng SS; Luo M; Chai JJ; Xu Y; Chen CL; Qiu L; Ke Q; Duan QW; Song SM; Shen L; Luo ZG
J Recept Signal Transduct Res; 2020 Dec; 40(6):541-549. PubMed ID: 32515250
[No Abstract] [Full Text] [Related]
6. Dimethoxycurcumin, a metabolically stable analogue of curcumin enhances the radiosensitivity of cancer cells: Possible involvement of ROS and thioredoxin reductase.
Jayakumar S; Patwardhan RS; Pal D; Sharma D; Sandur SK
Biochem Biophys Res Commun; 2016 Sep; 478(1):446-454. PubMed ID: 27381867
[TBL] [Abstract][Full Text] [Related]
7. Auranofin radiosensitizes tumor cells through targeting thioredoxin reductase and resulting overproduction of reactive oxygen species.
Wang H; Bouzakoura S; de Mey S; Jiang H; Law K; Dufait I; Corbet C; Verovski V; Gevaert T; Feron O; Van den Berge D; Storme G; De Ridder M
Oncotarget; 2017 May; 8(22):35728-35742. PubMed ID: 28415723
[TBL] [Abstract][Full Text] [Related]
8. Breast cancer suppression by curcumin-naringenin-magnetic-nano-particles: In vitro and in vivo studies.
Askar MA; El Shawi OE; Abou Zaid OAR; Mansour NA; Hanafy AM
Tumour Biol; 2021; 43(1):225-247. PubMed ID: 34542050
[TBL] [Abstract][Full Text] [Related]
9. Curcumin induces radiosensitivity of in vitro and in vivo cancer models by modulating pre-mRNA processing factor 4 (Prp4).
Shehzad A; Park JW; Lee J; Lee YS
Chem Biol Interact; 2013 Nov; 206(2):394-402. PubMed ID: 24144778
[TBL] [Abstract][Full Text] [Related]
10. The expression and activity of thioredoxin reductase 1 splice variants v1 and v2 regulate the expression of genes associated with differentiation and adhesion.
Nalvarte I; Damdimopoulos AE; Rüegg J; Spyrou G
Biosci Rep; 2015 Oct; 35(6):. PubMed ID: 26464515
[TBL] [Abstract][Full Text] [Related]
11. Molecular evidences for the chemosensitizing efficacy of liposomal curcumin in paclitaxel chemotherapy in mouse models of cervical cancer.
Sreekanth CN; Bava SV; Sreekumar E; Anto RJ
Oncogene; 2011 Jul; 30(28):3139-52. PubMed ID: 21317920
[TBL] [Abstract][Full Text] [Related]
12. Curcuminoid WZ26, a TrxR1 inhibitor, effectively inhibits colon cancer cell growth and enhances cisplatin-induced cell death through the induction of ROS.
Zhang T; Zheng P; Shen X; Shao R; Wang B; Shen H; Zhang J; Xia Y; Zou P
Free Radic Biol Med; 2019 Sep; 141():93-102. PubMed ID: 31176737
[TBL] [Abstract][Full Text] [Related]
13. Evidence for the use of curcumin in radioprotection and radiosensitization.
Boretti A
Phytother Res; 2024 Feb; 38(2):464-469. PubMed ID: 36897074
[TBL] [Abstract][Full Text] [Related]
14. Radiosensitizing effect of curcumin-loaded lipid nanoparticles in breast cancer cells.
Minafra L; Porcino N; Bravatà V; Gaglio D; Bonanomi M; Amore E; Cammarata FP; Russo G; Militello C; Savoca G; Baglio M; Abbate B; Iacoviello G; Evangelista G; Gilardi MC; Bondì ML; Forte GI
Sci Rep; 2019 Jul; 9(1):11134. PubMed ID: 31366901
[TBL] [Abstract][Full Text] [Related]
15. B5, a thioredoxin reductase inhibitor, induces apoptosis in human cervical cancer cells by suppressing the thioredoxin system, disrupting mitochondrion-dependent pathways and triggering autophagy.
Shao FY; Du ZY; Ma DL; Chen WB; Fu WY; Ruan BB; Rui W; Zhang JX; Wang S; Wong NS; Xiao H; Li MM; Liu X; Liu QY; Zhou XD; Yan HZ; Wang YF; Chen CY; Liu Z; Chen HY
Oncotarget; 2015 Oct; 6(31):30939-56. PubMed ID: 26439985
[TBL] [Abstract][Full Text] [Related]
16. Curcumin, a dietary component, has anticancer, chemosensitization, and radiosensitization effects by down-regulating the MDM2 oncogene through the PI3K/mTOR/ETS2 pathway.
Li M; Zhang Z; Hill DL; Wang H; Zhang R
Cancer Res; 2007 Mar; 67(5):1988-96. PubMed ID: 17332326
[TBL] [Abstract][Full Text] [Related]
17. Curcumin: a new radio-sensitizer of squamous cell carcinoma cells.
Khafif A; Hurst R; Kyker K; Fliss DM; Gil Z; Medina JE
Otolaryngol Head Neck Surg; 2005 Feb; 132(2):317-21. PubMed ID: 15692547
[TBL] [Abstract][Full Text] [Related]
18. T63, a new 4-arylidene curcumin analogue, induces cell cycle arrest and apoptosis through activation of the reactive oxygen species-FOXO3a pathway in lung cancer cells.
Liu H; Zhou BH; Qiu X; Wang HS; Zhang F; Fang R; Wang XF; Cai SH; Du J; Bu XZ
Free Radic Biol Med; 2012 Dec; 53(12):2204-17. PubMed ID: 23085518
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo radiosensitization with AZD6244 (ARRY-142886), an inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 kinase.
Chung EJ; Brown AP; Asano H; Mandler M; Burgan WE; Carter D; Camphausen K; Citrin D
Clin Cancer Res; 2009 May; 15(9):3050-7. PubMed ID: 19366835
[TBL] [Abstract][Full Text] [Related]
20. Curcumin stimulates reactive oxygen species production and potentiates apoptosis induction by the antitumor drugs arsenic trioxide and lonidamine in human myeloid leukemia cell lines.
Sánchez Y; Simón GP; Calviño E; de Blas E; Aller P
J Pharmacol Exp Ther; 2010 Oct; 335(1):114-23. PubMed ID: 20605902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
